Crossref
Advancements in liquid biopsy for gastrointestinal cancers receiving RTK-targeted therapies: Predicting treatment response and monitoring disease progression
The Nucleus · 09.07.2026
DOI: 10.1007/s13237-026-00693-z ↗Kurz gefasst
Fachartikel in der Zeitschrift The Nucleus, online erschienen am 09.07.2026. Verfasst von Amirhossein Molaei und 2 weiteren Autor:innen. Die Arbeit nennt 106 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Molaei, A., Kermani, F., & Goleij, P. (2026). Advancements in liquid biopsy for gastrointestinal cancers receiving RTK-targeted therapies: Predicting treatment response and monitoring disease progression. The Nucleus. https://doi.org/10.1007/s13237-026-00693-z
Vancouver
Molaei A, Kermani F, Goleij P. Advancements in liquid biopsy for gastrointestinal cancers receiving RTK-targeted therapies: Predicting treatment response and monitoring disease progression. The Nucleus. 2026. doi:10.1007/s13237-026-00693-z
BibTeX
@article{Molaei2026,
author = {Molaei, Amirhossein and Kermani, Farzaneh and Goleij, Pouya},
title = {Advancements in liquid biopsy for gastrointestinal cancers receiving RTK-targeted therapies: Predicting treatment response and monitoring disease progression},
journal = {The Nucleus},
year = {2026},
doi = {10.1007/s13237-026-00693-z}
}
EUVIMED